Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
Liver fibrosis is the excessive extracellular matrix accumulation of proteins, such as collagen, which follows the chronic liver diseases. Advanced liver fibrosis leads to cirrhosis and liver failure. Nilotinib is a second-generation tyrosine kinase inhibitor, which showed antifibrotic efficacy. Ste...
Saved in:
Main Authors: | Gamal Shiha, Ahmed Nabil, Ahmed Lotfy, Reham Soliman, Ayman A. Hassan, Islam S. Ali, Doaa F. Gad, Faten Zahran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2020/6574010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pretreatment with G-CSF Could Enhance the Antifibrotic Effect of BM-MSCs on Pulmonary Fibrosis
by: Feiyan Zhao, et al.
Published: (2019-01-01) -
Antifibrotic Activity of Acylated and Unacylated Ghrelin
by: Elia Angelino, et al.
Published: (2015-01-01) -
Antifibrotic Effect of Lactulose on a Methotrexate-Induced Liver Injury Model
by: Banu Taskin, et al.
Published: (2017-01-01) -
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
by: Raanan Greenman, et al.
Published: (2025-01-01) -
Diethylcarbamazine Reduces Chronic Inflammation and Fibrosis in Carbon Tetrachloride- (CCl4-) Induced Liver Injury in Mice
by: Sura Wanessa Santos Rocha, et al.
Published: (2014-01-01)